InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Murray Mark Anthony. Officer active across 2 companies, notably Oyster Point Pharma, Inc.. Aggregated, 3 reports have been recorded. History available since 7 June 2021. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Murray Mark Anthony
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
118,513 股Common StockSEC:0001209191-23-001077:0
3,573 股0Common StockSEC:0001209191-22-035059:0
3,466 股0Common StockSEC:0001209191-21-039334:0
3 条申报中的 3 条
About Murray Mark Anthony
Murray Mark Anthony is a declarant linked to Oyster Point Pharma, Inc., where he is a director. He has 4 filings in total, and among the sampled recent filings, the period runs from 2021-06-09 to 2023-01-04, with the modal transaction nature listed as Attribution.
